健康リスク評価のためのヒトの肝臓X受容体ベータとBPAとその類似体の相互作用を評価するためのコンピューティングフレームワーク

Rajesh Kumar Pathak^1,2, Saurav Kumar^1,3, Vikas Kumar^1,2,3

¹Pere Virgili Institute for Health Research (IISPV), Tarragona 43005, Spain.

|February 16, 2026

まとめ

多くのビスフェノールA (BPA) の代替品は,BPA自体よりも肝臓X受容体β (LXRβ) に強い結合を示しています. この計算による研究では,BPAの代替品の中には,BPAよりも肝臓の毒性のリスクが大きい可能性があることが示唆されています.

科学分野:

毒理学毒理学毒理学
コンピューティング・ケミストリー
薬理学薬理学とは

背景:

ビスフェノールA (BPA) を含むビスフェノールは,消費製品に多く含まれ,内分泌機能障害と肝臓疾患に関連しています.
BPAの毒性は,肝臓の代謝,特に肝臓X受容体-β (LXRβ) 経由での作用が完全に理解されていない構造的類似物の使用を促進し,制限につながりました.

研究の目的:

計算的方法を使用してBPAアナログとLXRβの相互作用を調査する.
BPAの代替品の潜在的肝毒性を評価するために,それらの結合親和性と薬理動力学/薬理動力学特性を評価する.

主な方法:

分子ドッキングは,BPAとG58を参照としてBPAとG58を用いて,BPAアナログのLXRβへの結合を予測するために使用されました.
トップ10のアナログの薬理動力学および薬理動力学特性が評価されました.
分子ダイナミクスシミュレーションとMM-PBSA計算を使用して,結合自由エネルギーとダイナミック相互作用を分析しました.

主要な成果:

いくつかのBPAアナログは,BPAと比較して,LXRβに対する予測されたより強い結合親和性を示しました.
いくつかの類似品は,BPA.に類似する薬理動力学および薬理動力学的プロファイルを示した.
LXRβに対する特定のアナログの強化された結合は,それらの潜在的な肝毒性に関する懸念を提起しています.

結論:

このin silicoの研究は,一般的に使用されるBPAの代替品は,BPAよりも高い肝毒性リスクをもたらす可能性があると予測しています.
計算によるアプローチは,実験的な安全性評価,特にBPAの代用品の化学薬品の優先順位を決めるのに価値があります.

さらに関連する動画

07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

6.7K

11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.8K

関連する概念動画

01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

322

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...

322

01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

01:31

Transducer Mechanism: Nuclear Receptors

2.6K

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

2.6K

01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...

01:28

Structure-Activity Relationships and Drug Design

1.8K

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

1.8K

01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

488

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

488

関連する実験動画